Lt. Martin et al., EFFECT OF STEREOISOMERISM ON THE CELLULAR PHARMACOLOGY OF BETA-ENANTIOMERS OF CYTIDINE ANALOGS IN HEP-G2 CELLS, Biochemical pharmacology, 53(1), 1997, pp. 75-87
The beta-L enantiomers of 2',3'-dideoxycytidine (beta-L-ddC) and its 5
-fluoro derivative, 2',3'-dideoxy-5-fluorocytidine (beta-L-FddC), were
demonstrated to be active against human immunodeficiency virus (HIV)
and hepatitis B virus (HBV) replication in vitro. In the present study
, we investigated the cellular pharmacology of beta-L-ddC and beta-L-F
ddC and compared it with that of beta-D-2',3'-dideoxy-5-fluorocytidine
(beta-D-FddC). beta-L-FddC (10 mu M) was found to be phosphorylated r
apidly in Hep-G2 cells to its 5'-mono-, di-, and triphosphate derivati
ves with intracellular triphosphate levels achieving 26.6 +/- 10.9 pmo
l/10(6) cells after 72 hr. In contrast, the active 5'-phosphorylated d
erivative of beta-D-FddC achieved lower levels with triphosphate level
s of only 23 +/- 0.5 pmol/10(6) cells under the same conditions. beta-
L-ddC was also phosphorylated rapidly. A 5'-diphosphocholine (18.7 +/-
5.8 pmol/10(6) cells) and a 5'-diphosphoethanolamine (13.6 +/- 0.9 pm
ol/10(6) cells) derivative were detected in beta-D-FddC-treated cells
after 72 hr, whereas in beta-L-FddC- and beta-L-ddC-treated cells, onl
y the 5'-diphosphocholine derivative (10.9 +/- 2.8 and 60.4 +/- 5.7 pm
ol/10(6) cells, respectively) was detected. beta-L-FddC-5'-triphosphat
e (beta-L-FddCTP), beta-D-FddC-5'-triphosphate (beta-D-FddCTP), and be
ta-L-ddC-5'-triphosphate (beta-L-ddCTP) followed a single phase elimin
ation process with an intracellular half-life (T-1/2) of 10.5, 5.7, an
d 12.3 hr, respectively. Furthermore, beta-L-FddCTP, beta-D-FddCTP, an
d beta-L-ddCTP levels of 6.7 +/- 2.3, 0.3 +/- 0.1, and 12.0 pmol/10(6)
cells, respectively, were still detectable 24 hr following drug remov
al. The higher intracellular 5'-triphosphate levels of beta-L-FddC and
the extended T-1/2 of its 5'-triphosphate are consistent with the mor
e potent in vitro antiviral activity of beta-L-FddC in Hep-G2 cells wh
en compared with its beta-D enantiomer, beta-D-FddC. Copyright (C) 199
6 Elsevier Science Inc.